Literature DB >> 27264673

A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.

Karen W Gripp1, Kimberly A Aldinger2, James T Bennett2,3, Laura Baker1, Jessica Tusi1, Nina Powell-Hamilton1, Deborah Stabley4, Katia Sol-Church4, Andrew E Timms5, William B Dobyns2.   

Abstract

Noonan syndrome is a rasopathy caused by mutations in multiple genes encoding components of the RAS/MAPK pathway. Despite its variable phenotype, limited genotype-phenotype correlations exist. Noonan syndrome with loose anagen hair (NS-LAH) is characterized by its distinctive hair anomalies, developmental differences, and structural brain abnormalities and is caused by a single recurrent missense SHOC2 mutation. SHOC2 forms a complex with protein phosphatase 1 (PP1C). Protein phosphatases counterbalance kinases and control activation of signaling proteins, such as the mitogen-activated protein kinases of the RAS/MAPK pathway. Here we report four patients with de novo missense mutations in protein phosphatase one catalytic subunit beta (PPP1CB), sharing a recognizable phenotype. Three individuals had the recurrent PPP1CB c.146G>C, p.Pro49Arg mutation, the fourth had a c.166G>C, p.Ala56Pro change. All had relative or absolute macrocephaly, low-set and posteriorly angulated ears, and developmental delay. Slow growing and/or sparse hair and/or an unruly hair texture was present in all. Three individuals had feeding difficulties requiring feeding tubes. One of two males had cryptorchidism, another had pectus excavatum. Short stature was present in three. A female with the recurrent mutation had a Dandy-Walker malformation and optic nerve hypoplasia. Mild ventriculomegaly occurred in all, cerebellar tonsillar ectopia was seen in two and progressed to Chiari 1 malformation in one individual. Based on the combination of phenotypic findings and PPP1CB's effect on RAF dephosphorylation within the RAS/MAPK pathway, this novel condition can be considered a rasopathy, most similar to NS-LAH. Collectively, these mutations meet the standardized criteria for pathogenicity.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Dandy-Walker malformation; Noonan syndrome; PPP1CB; developmental delay; loose anagen hair; rasopathy; short stature

Mesh:

Substances:

Year:  2016        PMID: 27264673      PMCID: PMC5134331          DOI: 10.1002/ajmg.a.37781

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

Review 1.  [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].

Authors:  Ismael Ejarque; José M Millán-Salvador; Silvestre Oltra; José V Pesudo-Martínez; Magdalena Beneyto; Antonio Pérez-Aytés
Journal:  Rev Neurol       Date:  2015-05-01       Impact factor: 0.870

2.  A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.

Authors:  Karen W Gripp; Eugenia Bifeld; Deborah L Stabley; Elizabeth Hopkins; Stefanie Meien; Kathy Vinette; Katia Sol-Church; Georg Rosenberger
Journal:  Am J Med Genet A       Date:  2012-07-20       Impact factor: 2.802

3.  Association between Noonan syndrome and Chiari I malformation: a case-based update.

Authors:  Yann Shern Keh; Laurence Abernethy; Benedetta Pettorini
Journal:  Childs Nerv Syst       Date:  2012-12-14       Impact factor: 1.475

4.  The perinatal presentation of cardiofaciocutaneous syndrome.

Authors:  Kara N Wong Ramsey; Matthew H Loichinger; Thomas P Slavin; Sheree Kuo; Laurie H Seaver
Journal:  Am J Med Genet A       Date:  2014-04-09       Impact factor: 2.802

5.  Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation.

Authors:  Yuri A Zarate; Angie W Lichty; Kristen J Champion; L Kate Clarkson; Kenton R Holden; M Gisele Matheus
Journal:  J Child Neurol       Date:  2013-07-21       Impact factor: 1.987

Review 6.  Leopard syndrome and Chiari type I malformation: a case report and review of the literature.

Authors:  Alexandra D Beier; Ryan J Barrett; Kelly Burke; Bruce Kole; Teck M Soo
Journal:  Neurologist       Date:  2009-01       Impact factor: 1.398

7.  Functional and evolutionary insights into human brain development through global transcriptome analysis.

Authors:  Matthew B Johnson; Yuka Imamura Kawasawa; Christopher E Mason; Zeljka Krsnik; Giovanni Coppola; Darko Bogdanović; Daniel H Geschwind; Shrikant M Mane; Matthew W State; Nenad Sestan
Journal:  Neuron       Date:  2009-05-28       Impact factor: 17.173

8.  Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.

Authors:  Viviana Cordeddu; Elia Di Schiavi; Len A Pennacchio; Avi Ma'ayan; Anna Sarkozy; Valentina Fodale; Serena Cecchetti; Alessio Cardinale; Joel Martin; Wendy Schackwitz; Anna Lipzen; Giuseppe Zampino; Laura Mazzanti; Maria C Digilio; Simone Martinelli; Elisabetta Flex; Francesca Lepri; Deborah Bartholdi; Kerstin Kutsche; Giovanni B Ferrero; Cecilia Anichini; Angelo Selicorni; Cesare Rossi; Romano Tenconi; Martin Zenker; Daniela Merlo; Bruno Dallapiccola; Ravi Iyengar; Paolo Bazzicalupo; Bruce D Gelb; Marco Tartaglia
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

9.  Clinical application of whole-exome sequencing across clinical indications.

Authors:  Kyle Retterer; Jane Juusola; Megan T Cho; Patrik Vitazka; Francisca Millan; Federica Gibellini; Annette Vertino-Bell; Nizar Smaoui; Julie Neidich; Kristin G Monaghan; Dianalee McKnight; Renkui Bai; Sharon Suchy; Bethany Friedman; Jackie Tahiliani; Daniel Pineda-Alvarez; Gabriele Richard; Tracy Brandt; Eden Haverfield; Wendy K Chung; Sherri Bale
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more
  37 in total

1.  Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.

Authors:  Tetsuya Niihori; Koki Nagai; Atsushi Fujita; Hirofumi Ohashi; Nobuhiko Okamoto; Satoshi Okada; Atsuko Harada; Hirotaka Kihara; Thomas Arbogast; Ryo Funayama; Matsuyuki Shirota; Keiko Nakayama; Taiki Abe; Shin-Ichi Inoue; I-Chun Tsai; Naomichi Matsumoto; Erica E Davis; Nicholas Katsanis; Yoko Aoki
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

2.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

Review 3.  RAS Proteins and Their Regulators in Human Disease.

Authors:  Dhirendra K Simanshu; Dwight V Nissley; Frank McCormick
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

Review 4.  Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.

Authors:  Victoria L Patterson; Rebecca D Burdine
Journal:  Birth Defects Res       Date:  2020-06-07       Impact factor: 2.344

5.  Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.

Authors:  Rita Sulahian; Jason J Kwon; Katherine H Walsh; Emma Pailler; Timothy L Bosse; Maneesha Thaker; Diego Almanza; Joshua M Dempster; Joshua Pan; Federica Piccioni; Nancy Dumont; Alfredo Gonzalez; Jonathan Rennhack; Behnam Nabet; John A Bachman; Amy Goodale; Yenarae Lee; Mukta Bagul; Rosy Liao; Adrija Navarro; Tina L Yuan; Raymond W S Ng; Srivatsan Raghavan; Nathanael S Gray; Aviad Tsherniak; Francisca Vazquez; David E Root; Ari J Firestone; Jeff Settleman; William C Hahn; Andrew J Aguirre
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

6.  Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy.

Authors:  Erin M Higgins; J Martijn Bos; Heather Mason-Suares; David J Tester; Jaeger P Ackerman; Calum A MacRae; Katia Sol-Church; Karen W Gripp; Raul Urrutia; Michael J Ackerman
Journal:  JCI Insight       Date:  2017-03-09

7.  Genotype and phenotype spectrum of NRAS germline variants.

Authors:  Franziska Altmüller; Christina Lissewski; Debora Bertola; Elisabetta Flex; Zornitza Stark; Stephanie Spranger; Gareth Baynam; Michelle Buscarilli; Sarah Dyack; Jane Gillis; Helger G Yntema; Francesca Pantaleoni; Rosa LE van Loon; Sara MacKay; Kym Mina; Ina Schanze; Tiong Yang Tan; Maie Walsh; Susan M White; Marena R Niewisch; Sixto García-Miñaúr; Diego Plaza; Mohammad Reza Ahmadian; Hélène Cavé; Marco Tartaglia; Martin Zenker
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

8.  Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.

Authors:  Débora Bertola; Michelle Buscarilli; Deborah L Stabley; Laura Baker; Daniel Doyle; Dennis W Bartholomew; Katia Sol-Church; Karen W Gripp
Journal:  Am J Med Genet A       Date:  2017-04-03       Impact factor: 2.802

9.  De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease.

Authors:  Lijiang Ma; Yavuz Bayram; Heather M McLaughlin; Megan T Cho; Alyson Krokosky; Clesson E Turner; Kristin Lindstrom; Caleb P Bupp; Katey Mayberry; Weiyi Mu; Joann Bodurtha; Veronique Weinstein; Neda Zadeh; Wendy Alcaraz; Zöe Powis; Yunru Shao; Daryl A Scott; Andrea M Lewis; Janson J White; Shalani N Jhangiani; Elif Yilmaz Gulec; Seema R Lalani; James R Lupski; Kyle Retterer; Rhonda E Schnur; Ingrid M Wentzensen; Sherri Bale; Wendy K Chung
Journal:  Hum Genet       Date:  2016-09-28       Impact factor: 4.132

10.  SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.

Authors:  Lucy C Young; Nicole Hartig; Isabel Boned Del Río; Sibel Sari; Benjamin Ringham-Terry; Joshua R Wainwright; Greg G Jones; Frank McCormick; Pablo Rodriguez-Viciana
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.